This study is evaluating whether in-utero exposures to maternal PFCs and PBDEs, individually and/or in combination, are associated with infant growth, adiposity, and neurodevelopment; metabolic determinants of obesity; and neurodevelopment and infant patterns of DNA methylation. The study also aims to identify infant, maternal, and paternal factors that modify the association of exposure to in-utero PFCs and PBDEs exposures with infant growth, adiposity, and neurodevelopment.
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment – DUPLICATED DO NOT ACTIVATE
Investigator: Ferrara, Assiamira
Funder: National Institutes of Health, Office of the Director